User profiles for Jim Koeller

Jim Koeller

Verified email at uthscsa.edu
Cited by 2817

Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer

JR Murillo Jr, J Koeller - The oncologist, 2006 - academic.oup.com
Purpose. To characterize the chemotherapy given near the end of life to advanced non-small
cell lung cancer (NSCLC) patients treated in the community oncology setting using a …

Antiemetic guidelines: creating a more practical treatment approach

JM Koeller, MS Aapro, RJ Gralla, SM Grunberg… - Supportive Care in …, 2002 - Springer
Antiemetic guidelines from a variety of professional organizations have been available for
several years. It is unclear just how often these guidelines have been used, however; data …

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy

…, LH Einhorn, S Grunberg, J Koeller… - Supportive Care in …, 2005 - Springer
This paper uses an evidence-based approach whenever possible to formulate recommendations,
emphasizing the results of controlled trials concerning the best use of antiemetic …

Electrocardiographic and Cardiovascular Effects of the 5-Hydroxytryptamine3 Receptor Antagonists

RM Navari, JM Koeller - Annals of Pharmacotherapy, 2003 - journals.sagepub.com
OBJECTIVE: To review the electrocardiographic (ECG) and cardiovascular effects of 5-hydroxytryptamine
3 (5-HT 3 ) receptor antagonists preclinically, in healthy volunteers, and in …

Fenofibrate-associated nephrotoxicity: a review of current evidence

…, CR Frei, L Ryan, JIM Koeller… - American journal of …, 2013 - academic.oup.com
Purpose The literature describing fenofibrate-associated nephrotoxicity was reviewed.
Summary Fenofibrate-associated nephrotoxicity is an underrecognized adverse effect that is …

Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research …

…, RT Attridge, EM Mortensen, J Koeller… - The Journal of the …, 2013 - Am Board Family Med
Objective: To measure the incidence of treatment failure and associated costs in patients with
methicillin-resistant Staphylococcus aureus skin and soft tissue infections (SSTIs). Methods…

[HTML][HTML] National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014

…, KA Lawson, EM Mortensen, MJV Pugh, JM Koeller… - PLoS …, 2017 - journals.plos.org
Introduction Prior studies demonstrated marked increases in Clostridium difficile infection (CDI)
in the United States (US) in recent years. The objective of this study was to describe the …

[HTML][HTML] National disparities in antibiotic prescribing by race, ethnicity, age group, and sex in United States ambulatory care visits, 2009 to 2016

EH Young, KA Strey, GC Lee, TJ Carlson, JM Koeller… - Antibiotics, 2022 - mdpi.com
While efforts have been made in the United States (US) to optimize antimicrobial use, few
studies have explored antibiotic prescribing disparities that may drive future interventions. The …

Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting

…, RE Greene, P Kwan, J Simon, JM Koeller - The …, 2008 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Identify reported
differences between advanced colorectal cancer patients treated in community oncology …

Documenting the benefits and cost savings of a large multistate cancer pathway program from a payer's perspective

ED Kreys, JM Koeller - Journal of Oncology Practice, 2013 - ascopubs.org
Purpose: Clinical pathways are viewed as valuable practice tools leading to presumed cost
savings. CareFirst BlueCross BlueShield partnering with P4 Pathways implemented a …